Dr. Lal Pathlabs Q2 Results
- BSE: 539524
- NSE: LALPATHLAB
- ISIN: INE600L01024
- Sector: Healthcare Facilities
BSE
2,811.7
0.70 (0.02%)
0.70 (0.02%)Volume969.00
Updated: Fri 17 Jan, 2025 | 15:24:12
NSE
2,810.05
-3.40 (-0.12%)
-3.40 (-0.12%)Volume50.90 K
Updated: Fri 17 Jan, 2025 | 15:43:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹660.20 Cr.(9.80%)
- Operating Profit₹167.20 Cr.(17.83%)
- Profit After Tax₹129.20 Cr.(18.21%)
- Operating Margin25.33%(7.32%)
Note: Comparison is on YoY basis
Quarterly - Dr. Lal Pathlabs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 660.20 | 601.90 | 9.69% | 601.30 | 9.80% |
| Selling/ General/ Admin Expenses Total | 217.70 | 200.30 | 8.69% | 190.60 | 14.22% |
| Depreciation/ Amortization | 35.30 | 34.70 | 1.73% | 35.90 | -1.67% |
| Other Operating Expenses Total | 112.70 | 112.20 | 0.45% | 110.50 | 1.99% |
| Total Operating Expense | 493.00 | 466.60 | 5.66% | 459.40 | 7.31% |
| Operating Income | 167.20 | 135.30 | 23.58% | 141.90 | 17.83% |
| Net Income Before Taxes | 183.10 | 149.90 | 22.15% | 152.20 | 20.30% |
| Net Income | 129.20 | 106.40 | 21.43% | 109.30 | 18.21% |
| Diluted Normalized EPS | 15.48 | 12.76 | 21.32% | 13.12 | 17.99% |